Inhibition of interleukin‐33 signaling attenuates the severity of experimental arthritis

Abstract

IL-33 is produced locally in inflamed joints, and neutralization of IL-33 signaling has a therapeutic effect on the course of arthritis. These observations suggest that locally produced IL-33 may contribute to the pathogenesis of joint inflammation and destruction.